Women’s health companies, once seen as niche, are gaining recognition as significant players in the healthcare industry. This shift is occurring as an unprecedented $124 trillion is expected to change hands over the next two decades, marking the largest intergenerational wealth transfer in history. A substantial portion of this wealth is moving to women through inheritance, entrepreneurship, and increased lifetime earnings. Concurrently, the healthcare sector is grappling with the realization that much of modern medicine has been predominantly based on male biology. These two developments are beginning to intersect, highlighting the need for more inclusive healthcare solutions that address the specific needs of women. This change not only reflects a broader societal shift towards gender equality but also underscores the importance of adapting healthcare to better serve all populations.
QUESTION: How might the increasing wealth and influence of women impact the future of healthcare and medical research?
Why VCs are suddenly obsessed with women’s health
